Arrowhead Pharmaceuticals, Inc.
ARWR · FY2025 · Fiscal year ended Sep 30, 2025 · 10-K filed Nov 2025
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $829M | $3.55M | +23,265% |
| Operating income | $98.3M | −$601M | |
| Net income | −$1.63M | −$599M | +99.7% |
Latest quarter: Q4 FY2026
Form 10-K · Three months ended Sep 30, 2026 (fourth quarter, from the 10-K) · filed Nov 12, 2026
| $ | Q4 FY2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $37.8M | $256M | −85.3% |
| Operating income | −$437M | $44.1M | |
| Net income | −$428M | −$23.8M | −1,698% |
Q4 FY2026 dashboardQ4 FY2026 infographic
Questions
- What was Arrowhead's revenue in FY2025?
- $829M in FY2025 (Fiscal year ended Sep 30, 2025), +23,265% vs $3.55M a year earlier, per its 10-K filed Nov 2025.
- Was Arrowhead profitable in FY2025?
- No: net income was −$1.63M and operating income $98.3M in FY2025.
- What was Arrowhead's revenue in Q4 FY2026?
- $37.8M (−85.3% vs a year earlier), per its Form 10-K filed Nov 12, 2026.